327 related articles for article (PubMed ID: 25436466)
1. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
Uddin R; Saeed K; Khan W; Azam SS; Wadood A
Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
Uddin R; Saeed K
Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
[TBL] [Abstract][Full Text] [Related]
3. Identification of putative drug targets in Vancomycin-resistant Staphylococcus aureus (VRSA) using computer aided protein data analysis.
Hasan MA; Khan MA; Sharmin T; Hasan Mazumder MH; Chowdhury AS
Gene; 2016 Jan; 575(1):132-43. PubMed ID: 26319513
[TBL] [Abstract][Full Text] [Related]
4. Comparative genomics study for the identification of drug and vaccine targets in Staphylococcus aureus: MurA ligase enzyme as a proposed candidate.
Ghosh S; Prava J; Samal HB; Suar M; Mahapatra RK
J Microbiol Methods; 2014 Jun; 101():1-8. PubMed ID: 24685600
[TBL] [Abstract][Full Text] [Related]
5. Mycoplasma genitalium: a comparative genomics study of metabolic pathways for the identification of drug and vaccine targets.
Butt AM; Tahir S; Nasrullah I; Idrees M; Lu J; Tong Y
Infect Genet Evol; 2012 Jan; 12(1):53-62. PubMed ID: 22057004
[TBL] [Abstract][Full Text] [Related]
6. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
Uddin R; Masood F; Azam SS; Wadood A
Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach.
Uddin R; Siddiqui QN; Azam SS; Saima B; Wadood A
Eur J Pharm Sci; 2018 Mar; 114():13-23. PubMed ID: 29174549
[TBL] [Abstract][Full Text] [Related]
8. Glutamate synthase: A case-study for in silico drug screening on a complex iron-sulfur flavoenzyme?
Vanoni MA
Gene; 2015 Jun; 564(2):233-5. PubMed ID: 25861867
[No Abstract] [Full Text] [Related]
9. Functional analysis, overexpression, and kinetic characterization of pyruvate kinase from methicillin-resistant Staphylococcus aureus.
Zoraghi R; See RH; Gong H; Lian T; Swayze R; Finlay BB; Brunham RC; McMaster WR; Reiner NE
Biochemistry; 2010 Sep; 49(35):7733-47. PubMed ID: 20707314
[TBL] [Abstract][Full Text] [Related]
10. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
Uddin R; Sufian M
PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
[TBL] [Abstract][Full Text] [Related]
12. Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB.
Kaur N; Khokhar M; Jain V; Bharatam PV; Sandhir R; Tewari R
Appl Biochem Biotechnol; 2013 Sep; 171(2):417-36. PubMed ID: 23846799
[TBL] [Abstract][Full Text] [Related]
13. Comparative genomics study of Salmonella Typhimurium LT2 for the identification of putative therapeutic candidates.
Samal HB; Prava J; Suar M; Mahapatra RK
J Theor Biol; 2015 Mar; 369():67-79. PubMed ID: 25637765
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity, computational analysis and host toxicity study of thymol-sulfonamide conjugates.
Swain SS; Paidesetty SK; Padhy RN
Biomed Pharmacother; 2017 Apr; 88():181-193. PubMed ID: 28107695
[TBL] [Abstract][Full Text] [Related]
15. Auxiliary factors: a chink in the armor of MRSA resistance to β-lactam antibiotics.
Roemer T; Schneider T; Pinho MG
Curr Opin Microbiol; 2013 Oct; 16(5):538-48. PubMed ID: 23895826
[TBL] [Abstract][Full Text] [Related]
16. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.
Tan CM; Therien AG; Lu J; Lee SH; Caron A; Gill CJ; Lebeau-Jacob C; Benton-Perdomo L; Monteiro JM; Pereira PM; Elsen NL; Wu J; Deschamps K; Petcu M; Wong S; Daigneault E; Kramer S; Liang L; Maxwell E; Claveau D; Vaillancourt J; Skorey K; Tam J; Wang H; Meredith TC; Sillaots S; Wang-Jarantow L; Ramtohul Y; Langlois E; Landry F; Reid JC; Parthasarathy G; Sharma S; Baryshnikova A; Lumb KJ; Pinho MG; Soisson SM; Roemer T
Sci Transl Med; 2012 Mar; 4(126):126ra35. PubMed ID: 22440737
[TBL] [Abstract][Full Text] [Related]
17. Identification of Putative Vaccine and Drug Targets against the Methicillin-Resistant
Naorem RS; Pangabam BD; Bora SS; Goswami G; Barooah M; Hazarika DJ; Fekete C
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408485
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential drug targets by subtractive genome analysis of Bacillus anthracis A0248: An in silico approach.
Rahman A; Noore S; Hasan A; Ullah R; Rahman H; Hossain A; Ali Y; Islam S
Comput Biol Chem; 2014 Oct; 52():66-72. PubMed ID: 25254941
[TBL] [Abstract][Full Text] [Related]
19. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis.
Anishetty S; Pulimi M; Pennathur G
Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791
[TBL] [Abstract][Full Text] [Related]
20. Nitric Oxide Synthase as a Target for Methicillin-Resistant Staphylococcus aureus.
Holden JK; Kang S; Beasley FC; Cinelli MA; Li H; Roy SG; Dejam D; Edinger AL; Nizet V; Silverman RB; Poulos TL
Chem Biol; 2015 Jun; 22(6):785-92. PubMed ID: 26091171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
